The American Society Of Gene & Cell Therapy
Waukesha, Wisconsin
Financial Health Score
9-metric score across financial health, operational efficiency, and organizational resilience. Based on IRS Form 990 data.
Very Good
How This Organization Compares
Compared to 5 peers in Medical Research with $10M-$100M revenue
Working Capital Ratio (net assets ÷ expenses)
Financial Trends
5-Year Trend Analysis
Financial Health Indicators
Filing History
14 filings on record| Year | Revenue | Expenses | Assets | |
|---|---|---|---|---|
| 2023 | $16,370,708↑31% | $13,754,627↑26% | $23,810,378↑16% | — |
| 2022 | $12,483,052↑40% | $10,958,628↑78% | $20,486,557↑33% | — |
| 2021 | $8,934,604↑37% | $6,172,037↑37% | $15,452,389↑34% | — |
| 2020 | $6,516,210 | $4,511,431↓4% | $11,546,982↑19% | — |
| 2019 | $6,509,265↑32% | $4,691,842↑38% | $9,695,835↑37% | — |
| 2018 | $4,930,268↑40% | $3,397,539↑52% | $7,087,668↑33% | — |
| 2017 | $3,515,107↑36% | $2,240,434↑16% | $5,317,511↑34% | — |
| 2016 | $2,586,721↑17% | $1,929,028↑3% | $3,972,524↑47% | — |
| 2015 | $2,219,363↑10% | $1,865,825↑11% | $2,700,093↑18% | — |
| 2014 | $2,023,508↑21% | $1,675,652↑15% | $2,288,765↑18% | — |
| 2013 | $1,672,853↓12% | $1,450,850↓4% | $1,931,909↑15% | — |
| 2012 | $1,908,051↑23% | $1,503,644↓6% | $1,674,753↑29% | — |
| 2011 | $1,547,828↓6% | $1,593,491↑13% | $1,293,383↓3% | — |
| 2010 | $1,642,850 | $1,406,915 | $1,336,530 | — |
Frequently Asked Questions
What does The American Society Of Gene & Cell Therapy do?▼
The American Society Of Gene & Cell Therapy is a medical research nonprofit organization based in Wisconsin. It is classified under NTEE code H20 and is registered as a 501(c) tax-exempt organization with the IRS.
Is The American Society Of Gene & Cell Therapy financially healthy?▼
Based on our 9-metric Financial Health Score model, The American Society Of Gene & Cell Therapy has a score of 84/100 (Grade: A-). This score evaluates working capital, surplus consistency, debt ratio, revenue trends, program spending, fundraising efficiency, executive compensation, revenue diversification, and vulnerability indicators.
How much revenue does The American Society Of Gene & Cell Therapy generate?▼
The American Society Of Gene & Cell Therapy reports $16.9M in annual revenue and holds $27.0M in total assets, based on IRS filings.
Similar Organizations
Explore more organizations in the Medical Research category, or browse all nonprofits in Wisconsin.